Using sub-cellular fractionation studies, on Dok1 and BRK-positive breast cancer cell lines, SKBR3 and BT20, we found that both BRK and Dok1 fractionated to the cytosolic and membrane fractions (Figure 4B and 4C). This evidence concerns the gene DOK1 and breast carcinoma.